id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-P-1962-0006,FDA,FDA-2016-P-1962,"Letter from FDA CDER to Hyman, Phelps, and McNamara, P.C.",Other,Partial Petition Approval and Denial,2018-12-31T05:00:00Z,2018,12,2018-12-31T05:00:00Z,,2018-12-31T22:07:39Z,,0,0,09000064839d2016
FDA-2016-P-1962-0005,FDA,FDA-2016-P-1962,FDA-2016-P-1962 Response to Comments,Other,Response(s),2018-07-16T04:00:00Z,2018,7,2018-07-16T04:00:00Z,,2018-07-16T14:19:12Z,,0,0,09000064835019a1
FDA-2016-P-1962-0003,FDA,FDA-2016-P-1962,"Interim Response Letter from FDA CDER to Hyman, Phelps & McNamara, PC",Other,Letter(s),2016-12-22T05:00:00Z,2016,12,2016-12-22T05:00:00Z,,2016-12-22T19:10:46Z,,0,0,0900006482431e45
FDA-2016-P-1962-0001,FDA,FDA-2016-P-1962,"Citizen Petition from Hyman, Phelps & McNamara, PC (Allergan plc)",Other,Application for Variance (VAR),2016-07-11T04:00:00Z,2016,7,2016-07-11T04:00:00Z,2017-01-04T04:59:59Z,2016-12-22T02:00:39Z,,0,0,09000064820944d6
FDA-2016-P-1962-0002,FDA,FDA-2016-P-1962,"Acknowledgement Letter from FDA DDM to Hyman, Phelps & McNamara, PC",Other,Acknowledgement Letter/Receipt,2016-07-11T04:00:00Z,2016,7,2016-07-11T04:00:00Z,,2016-07-11T19:29:56Z,,0,0,09000064820944dc